ARROWGRASS CAPITAL PARTNERS (US) LP - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 363 filers reported holding VANECK VECTORS ETF TR in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.

Quarter-by-quarter ownership
ARROWGRASS CAPITAL PARTNERS (US) LP ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2019$15,336,000
-63.2%
600,000
-67.7%
0.36%
-70.5%
Q1 2019$41,701,000
+1877.3%
1,860,000
+1760.0%
1.23%
+1475.6%
Q4 2018$2,109,000
-84.8%
100,000
-86.7%
0.08%
-81.7%
Q3 2018$13,875,000
+231.6%
749,200
+37360.0%
0.43%
+808.5%
Q4 2016$4,184,0002,0000.05%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2016
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders